September 19, 2024 01:50 PM EDT

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Ryan Cross

Senior Science Correspondent

Three scientists whose work paved the way to the multibillion-dollar obesity drug boom have won the Lasker Award for “the discovery and development of GLP …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Exclusive: Degradation startup raises $39M for pivot to PROTACs and clinical entry

Singapore cardio gene therapy biotech collects $45M as it plots Europe expansion

Vertex touts promising first few months of launch for non-opioid pain drug Journavx

Bristol Myers to lay off over 500 workers in New Jersey

Early bits of in vivo CAR-T human data emerge from biotech trials in China

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

Lasker Award goes to three sci­en­tists who pi­o­neered re­search be­hind GLP-1 drugs

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Ex­clu­sive: Degra­da­tion start­up rais­es $39M for piv­ot to PRO­TACs and clin­i­cal en­try

Sin­ga­pore car­dio gene ther­a­py biotech col­lects $45M as it plots Eu­rope ex­pan­sion

Ver­tex touts promis­ing first few months of launch for non-opi­oid pain drug Jour­navx

Bris­tol My­ers to lay off over 500 work­ers in New Jer­sey

Ear­ly bits of in vi­vo CAR-T hu­man da­ta emerge from biotech tri­als in Chi­na

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Exclusive: Degradation startup raises $39M for pivot to PROTACs and clinical entry

Singapore cardio gene therapy biotech collects $45M as it plots Europe expansion

Vertex touts promising first few months of launch for non-opioid pain drug Journavx

Bristol Myers to lay off over 500 workers in New Jersey

Early bits of in vivo CAR-T human data emerge from biotech trials in China

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges